During the past decade, Hospital El Bierzo conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital El Bierzo" #1 sponsor was "Dr. Negrin University Hospital" with 2 trials, followed by "PETHEMA Foundation" with 2 trials sponsored, "Abbott Nutrition" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital El Bierzo" #1 collaborator was "Asociación Científica Pulmón y Ventilación Mecánica" with 2 trials as a collaborator, "Adknoma Health Research" with 1 trials as a collaborator, "BioClever 2005 S.L." with 1 trials as a collaborator, "Consorcio Centro de Investigación Biomédica en Red (CIBER)" with 1 trials as a collaborator and "Hospital Universitario Virgen Macarena" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Hospital El Bierzo" are "Acute Pain Due to Trauma" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Acute Respiratory Insufficiency" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Hospital El Bierzo" in a lesser frequency.

Most popular intervention types in "Hospital El Bierzo" are "Drug" (4 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Allergen extract (Phleum pratense)" (1 trials), "Bortezomib" (1 trials), "Ceramic on Ceramic articulation" (1 trials), "Ceramic on Polyethylene articulation" (1 trials) and "Daratumumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital El Bierzo" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Hospital El Bierzo". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hospital El Bierzo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital El Bierzo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".